UCB : presents latest data from generalized myasthenia gravis portfolio at 2023 AANEM Annual Meeting and MGFA Scientific Session -November 01, 2023 at 02:03 am EDT

UCB presents latest data from generalized myasthenia gravis portfolio at 2023 AANEM Annual Meeting and MGFA Scientific Session




14 presentations - including 3...

Related Keywords

Canada ,Australia ,Japan ,Belgium ,China ,Brussels ,Bruxelles Capitale ,Japanese ,Australian ,Kim Moran ,Antje Witte ,Laurent Schots ,Jim Baxter ,Howard Jf Jr ,Donatello Crocetta ,Scientific Program ,Global Rare Disease Communications ,Rare Disease Communications Japan ,Japanese Ministry Of Health ,Committee For Medicinal Products Human Use ,American Association Of Neuromuscular Electrodiagnostic Medicine ,National Institute Of Neurological Disorders ,Health Canada ,Ucb Inc ,Drug Administration ,European Medicines Agency ,Twitter ,Corporate Communications ,Myasthenia Gravis Foundation Of America ,European Union ,Australian Therapeutic Goods Administration ,Myasthenia Gravis Association Of America Scientific Session ,Euronext Brussels ,American Association ,Electrodiagnostic Medicine ,Myasthenia Gravis Association ,America Scientific Session ,Japanese Ministry ,Global Rare Disease ,Rare Medical ,New Treatment Landscape ,Myasthenia Gravis ,Medicinal Products ,Human Use ,Priority Review ,Biologic License Application ,Drug Evaluation ,China National Medical Products Administration ,Safety Information ,Patient Safety Card ,Patient Guide ,Prescribing Information ,Medication Guide ,Boxed Warning ,Serious Meningococcal ,Dose Prefilled ,Disease Communications ,Patients With Moderate ,Severe Generalized Myasthenia Gravis ,Multicenter Clinical ,Accessed October ,Neurological Disorders ,Gravis Fact ,Gravis Foundation ,Markets ,